That is a good look at the situation, still got to wonder how many 1.50 options Bruce got for doing double duty as CEO for both
and honestly I was always less impressed with the Canopy Rivers deal - the reason being is that I could see the need for having a private corp with the biotechnology issue to attract PhDs and organizations like that Brinkley thing or Dr. Marc Ware...
but Canopy Rivers is too much, I can't see any need for it - just greed